Zenotech Laboratories share news, announcements and annual reports
BSE: 532039Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 28 Oct 2026. Previous close ₹38.51.
28 Oct: open ₹38.58, high ₹38.89, low ₹37.58
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹231 Cr2,190th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.50
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −4.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −8.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 6,651
Zenotech Laboratories has 496 announcements on record, routine notices left out; 4 in the 30 days to 29 Oct 2026, the latest on 28 Oct 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Zenotech Laboratories quarterly results
The board met on 28 Oct 2026 to consider quarterly results
Notice filed 19 Oct 2026
Zenotech Laboratories annual reports, presentations and earnings calls
The company's own documents, latest first.Zenotech Laboratories financials, year by year
Annual reports24
- Annual report, year to Mar 202628 Aug 2026
- Annual report, year to Mar 20251 Sep 2025
- Annual report, year to Mar 20242 Sep 2024
- Annual report, year to Mar 20235 Sep 2023
- Annual report, year to Mar 202230 Aug 2022
19 earlier reports
- Annual report, year to Mar 20212 Sep 2021
- Annual report, year to Mar 20202 Sep 2020
- Annual report, year to Mar 201926 Aug 2019
- Annual report, year to Mar 201813 Oct 2018
- Annual report, year to Mar 201729 Sep 2017
- Annual report, year to Mar 201629 Sep 2016
- Annual report, year to Mar 20153 Feb 2016
- Annual report, year to Mar 20144 Sep 2014
- Annual report, year to Mar 201319 Jul 2013
- Annual report, year to Mar 20125 Dec 2012
- Annual report, year to Mar 20113 Jul 2012
- Annual report, year to Mar 20103 Jul 2012
- Annual report, year to Mar 2009Filing day not known
- Annual report, year to Mar 2008Filing day not known
- Annual report, year to Mar 2007Filing day not known
- Annual report, year to Mar 2006Filing day not known
- Annual report, year to Mar 2005Filing day not known
- Annual report, year to Mar 2004Filing day not known
- Annual report, year to Mar 2003Filing day not known
Zenotech Laboratories share news and announcements
Newest first. Page 1 of 10.
Oct 2026
19 Oct · Board meeting
Meeting on 28 Oct 2026: quarterly results
Sep 2026
Aug 2026
Jul 2026
28 Jul · Results
13 Jul · Board meeting
Meeting on 28 Jul 2026: quarterly results
Apr 2026
23 Apr · Board meeting
Meeting on 29 Apr 2026: audited results and quarterly results10 Apr · Legal
10 Apr · Legal
Exchange has sought clarification from Zenotech Laboratories Ltd on April 9, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Mar 2026
Feb 2026
9 Feb · Meeting
Jan 2026
23 Jan · Results
16 Jan · Board meeting
Meeting on 23 Jan 2026: quarterly results
Oct 2025
23 Oct · Board meeting
Meeting on 31 Oct 2025: quarterly results
Sep 2025
25 Sep · Board meeting
Meeting on 25 Sep 202525 Sep · Board meeting
25 Sep · Updation Of Address Of Registered Office Of The Company
Aug 2025
Jul 2025
28 Jul · Results
21 Jul · Board meeting
Meeting on 28 Jul 2025: quarterly results
Apr 2025
21 Apr · Board meeting
Meeting on 25 Apr 2025: audited results
Mar 2025
Feb 2025
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 23 Oct 2024Board or managers changeddown 4.52%−4.6 pts vs Nifty 500market median 0.0% · five sessions −7.5% (−7.4 pts vs Nifty 500) · volume 0.9× usual · The announcement
- 26 Jul 2024Board or managers changedup 3.39%+1.8 pts vs Nifty 500market median 0.0% · five sessions −1.6% (−4.2 pts vs Nifty 500) · volume 2.4× usual · The announcement
- 18 May 2024Board or managers changeddown 1.19%−1.6 pts vs Nifty 500market median 0.0% · five sessions −3.2% (−5.2 pts vs Nifty 500) · volume 0.3× usual · The announcement
- 22 Nov 2017Board or managers changedup 4.98%+4.9 pts vs Nifty 500market median 0.0% · five sessions +19.5% (+18.7 pts vs Nifty 500) · volume 2.8× usual · The announcement
- 17 Nov 2015Board or managers changeddown 0.25%−0.7 pts vs Nifty 500market median 0.0% · five sessions +0.9% (−0.1 pts vs Nifty 500) · volume 0.2× usual
- 2 Jun 2015Board or managers changeddown 1.98%+0.3 pts vs Nifty 500market median 0.0% · five sessions −9.4% (−4.7 pts vs Nifty 500) · volume 0.8× usual
- 26 Mar 2015Board or managers changedup 2.12%+3.9 pts vs Nifty 500market median 0.0% · five sessions +18.5% (+17.2 pts vs Nifty 500) · volume 0.9× usual
- 11 Jun 2014Board or managers changeddown 1.97%−1.3 pts vs Nifty 500market median 0.0% · five sessions −3.1% (−2.2 pts vs Nifty 500) · volume 0.5× usual
- 25 Feb 2014Board or managers changedup 1.83%+1.6 pts vs Nifty 500market median 0.0% · five sessions +8.2% (+6.3 pts vs Nifty 500) · volume 0.1× usual
Figures filed again
Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.
| Line | Period | Accounts | First filed | Filed again | Change. The value filed again less the value first filed, as a per cent of the first. | First filed on | Filed again on |
|---|---|---|---|---|---|---|---|
| Revenue from operations | Quarter to Jun 2024 | Standalone | 9.91 | 8.89 | −10.3% | 2 Aug 2024 | 29 Oct 2024 |
| Other income | Quarter to Jun 2024 | Standalone | 0.34 | 1.35 | +302.0% | 2 Aug 2024 | 29 Oct 2024 |